1 |
Bailey LB, Gregory JF (1999). Folate metabolism and requirements. J Nutrit, 129, 779-82.
|
2 |
Bax L, Yu LM, Ikeda N, et al (2006). Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol, 6, 50.
DOI
|
3 |
Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
DOI
ScienceOn
|
4 |
Blount BC, Mack MM, Wehr CM, et al (1997). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA, 94, 3290-5.
DOI
ScienceOn
|
5 |
Boccia S, Boffetta P, Brennan P, et al (2009). Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Lett, 273, 55-61.
DOI
ScienceOn
|
6 |
Botto LD, Yang Q (2000). 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol, 151, 862-77.
DOI
ScienceOn
|
7 |
Cheng Z, Wang W, Song YN, et al (2011). Investigation of the relationship between C677T polymorphisms of methylenetetra-hydrofolate reductase and lung cancer risk. Chin J Tuberc Respir Dis, 34, 57 58.
|
8 |
Cui LH, Shin MH, Kim HN, et al (2011a). Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population. BMC Med Genet, 12, 28.
|
9 |
Cui LH, Yu Z, Zhang TT, et al (2011b). Influence of polymorphisms in MTHFR 677 C/T, TYMS 3R/2R and MTR 2756 A/G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC. Pharmacogenomics, 12, 797-808.
DOI
ScienceOn
|
10 |
DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177-88.
DOI
ScienceOn
|
11 |
Duthie SJ (1999). Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull, 55, 578-92.
DOI
ScienceOn
|
12 |
Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
DOI
ScienceOn
|
13 |
Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
DOI
ScienceOn
|
14 |
Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methelenetetrahydrofolate reductase. Nat Genet, 10, 111-3
DOI
ScienceOn
|
15 |
Guan P, Huang D, Yin Z, et al (2011). Association of the hOGG1 Ser326Cys polymorphism with increased lung cancer susceptibility in Asians: a meta-analysis of 18 studies including 7592 cases and 8129 controls. Asian Pac J Cancer Prev, 12, 1067-72.
|
16 |
Goyette P, Sumner JS, Milos R, et al (1994). Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet, 7, 551.
|
17 |
Goyette P, Pai A, Milos R, et al (1998). Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome, 9, 652-6.
DOI
ScienceOn
|
18 |
Hegele RA, Tully C, Young TK, Connelly PW (1997). V677 mutation of methylenetetrahydrofolate reductases and cardiovascular disease in Canadian Inuit. Lancet, 349, 1221-2.
|
19 |
Hubner RA, Houlston RS (2007). MTHFR C677T and colorectal cancer risk: a meta analysis of 25 populations. Int J Cancer, 120, 1027-35.
|
20 |
Hung RJ, Hashibe M, McKay J, et al (2007). Folate-related genes and the risk of tobacco-related cancers. Carcinogenesis, 28, 1334-40.
DOI
ScienceOn
|
21 |
Jeng YL, Wu MH, Huang HB, et al (2003). The methylenetetrahydrofolate reductase 677C T polymorphism and lung cancer risk in a Chinese population. Anticancer Res, 23, 5149-52.
|
22 |
Jin C, Zhang YH, Peng MF, et al (2007). Study of the relationship between C677T, A1298C gene polymorphisms of methylenetetrahydrofolate reductase and lung cancer. Chin Clin Oncol, 12, 671-5.
|
23 |
Kim Y I, Pogribny I P, Basnakian AG, et al (1997). Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am J Clin Nutr, 65, 46-52.
|
24 |
Kim YI (1999). Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem, 10, 66-88.
DOI
ScienceOn
|
25 |
Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y (2011). Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case control study in a Japanese population. BMC Cancer, 11, 459.
DOI
|
26 |
Liang H, Yan Y, Li T, et al (2013). Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies. Tumor Biol, DOI 10.1007/s13277-013-1234-9.
|
27 |
Liao SG, Liu L, Zhang YY, et al (2012). SULT1A1 Arg213His polymorphism and lung cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 579-83.
과학기술학회마을
DOI
|
28 |
Liu CS, Tsai CW, Hsia TEC (2009). Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients. Cancer Genomics Proteomic, 6, 325-9.
|
29 |
Liu ZB, Wang LP, Shu J, Jin C, Lou ZX (2013). Methylenetetrahydrofolate reductase 677TT genotype might be associated with an increased lung cancer risk in Asians. Gene, 515, 214-9.
DOI
ScienceOn
|
30 |
Liu H, Jin G, Wang H, et al (2008). Association of polymorphisms in one-carbon metabolizing genes and lung cancer risk: a case-control study in Chinese population. Lung Cancer, 61, 21-9.
DOI
ScienceOn
|
31 |
Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
|
32 |
Mei Q, Zhou D, Gao J, et al (2012). The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis. BMC Cancer, 12, 467-76.
DOI
|
33 |
Pan F, Tian J, Pan Y, et al (2011). Lack of association of the cyclooxygenase 8473 T>C polymorphism with lung cancer: evidence from 9841 subjects. Asian Pac J Cancer Prev, 12, 1941-5.
|
34 |
Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
DOI
ScienceOn
|
35 |
Pepe G, Camacho Vanegas O, Giusti B, et al (1998). Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Am J Hum Genet, 63, 917-20.
DOI
ScienceOn
|
36 |
Rai V, Yadav U, Kumar P, Yadav SK (2010). Methyleletetrahydrofolate reductase polymorphism (C677T) in Muslim population of Eastern Uttar Pradesh, India. IJMS, 64, 219-23.
|
37 |
Rai V, Yadav U, Kumar P (2012). Prevalence of methylenetetrahydrofolate reductase C677T polymorphism in eastern Uttar Pradesh. Indian J Human Genetics, 18, 43-6.
DOI
|
38 |
Robien K, Ulrich CM (2003). 5,10- Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemio, 157, 571-82.
DOI
ScienceOn
|
39 |
Rai V (2011). Evaluation of methylenetetrahydrofolate reductase gene variant (C677T) as risk factor for bipolar disorder. Cell Mol Biol, 57, 1558-66.
|
40 |
Rai V (2014). Methylenetetrahydrofolate reductase gene A1298C polymorphism and susceptibility to recurrent pregnancy loss: a meta-analysis. Cell Mol Biol, 60, 27-34.
|
41 |
Sharp L, Little J (2004). Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol, 159, 423-43.
DOI
ScienceOn
|
42 |
Shen M, Rothman N, Berndt SI, et al (2005). Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer, 49, 299-309.
DOI
ScienceOn
|
43 |
Stern LL, Mason JB, Selhub J, Choi SW (2000). Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev, 9, 849-53.
|
44 |
Suzuki T, Matsuo K, Hiraki A, et al (2007). Impact of onecarbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case-control study. Carcinogenesis, 28, 1718-25.
DOI
ScienceOn
|
45 |
Tu YL, Wang SB, Tan XL (2012). MTHFR Gene polymorphisms are not involved in pancreatic cancer risk: A meta-analysis. Asian Pac J Cancer Prev, 13, 4627-30.
과학기술학회마을
DOI
|
46 |
Yadav U, Kumar P, Yadav SK, Mishra OP, Rai V (2014). Polymorphisms in folate metabolism genes as maternal risk factor for Neural Tube Defects: an updated meta-analysis. Metabolic Brain Disease.
|
47 |
Weisberg I, Tran P, Christensen B, et al (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab, 64, 169-72.
DOI
ScienceOn
|
48 |
Whitehead A (2002). Meta-analysis of controlled clinical trials. Wiley, Chichester, UK.
|
49 |
Yadav U, Kumar P, Rai V (2011). Docking study of MTHFR with FAD by Hex. J Comput Intell Bioinformatics, 4, 171-8.
|
50 |
Yang XX, Li FX, Yi JP, et al (2010). Polymorphisms of the methylenetetrahydrofolate reductase C677T and risk of gastric cancer, colon cancer and lung cancer. Guangdong Med J, 31, 2375-8.
|
51 |
Yao QF, Chen X, Xue JR, et al (2010). Relationship of polymorphisms of MTHFR gene hypermethylation of tumor suppressor gene in lung cancer. Cancer Res Prev Treat, 37, 531-4.
|
52 |
Zhang XM, Miao XP, Tan W, et al (2005). Association between genetic polymorphisms in methylentetrahydrofolate reductase and risk of lung cancer. Acta Academiae Medicinae Sinicae, 27, 700-3.
|
53 |
Zintzaras E, Hadjigeorgiou GM (2005). The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis. J Hum Genet, 50, 560-6.
DOI
|
54 |
Zintzaras E, Ioannidis JP (2005). Heterogeneity testing in meta analysis of genome searches. Genet Epidemiol, 28, 123-37.
DOI
ScienceOn
|
55 |
Zintzaras E (2007). Maternal gene polymorphisms involved in folate metabolism and risk of Down syndrome offspring: a meta-analysis. J Human Genetics, 52, 943-53.
DOI
|